Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Scalar Gauge Management LLC

Scalar Gauge Management LLC boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 44.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 27,400 shares of the biotechnology company’s stock after buying an additional 8,400 shares during the period. Axon Enterprise comprises approximately 7.5% of Scalar Gauge Management LLC’s investment portfolio, making the stock its 3rd biggest position. Scalar Gauge Management LLC’s holdings in Axon Enterprise were worth $16,284,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. Alliancebernstein L.P. increased its stake in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock worth $659,128,000 after purchasing an additional 812,337 shares during the period. O Shaughnessy Asset Management LLC grew its holdings in Axon Enterprise by 51.7% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 5,447 shares of the biotechnology company’s stock valued at $3,237,000 after buying an additional 1,856 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in Axon Enterprise by 697.1% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 7,357 shares of the biotechnology company’s stock worth $4,372,000 after buying an additional 6,434 shares during the period. Strategy Asset Managers LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $220,000. Finally, Allstate Corp bought a new stake in shares of Axon Enterprise in the fourth quarter valued at about $1,253,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

Shares of AXON stock opened at $534.95 on Monday. The business has a fifty day simple moving average of $589.62 and a 200 day simple moving average of $550.61. The company has a market cap of $40.99 billion, a P/E ratio of 138.23, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99.

Analyst Ratings Changes

AXON has been the subject of several analyst reports. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Finally, Needham & Company LLC restated a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Insiders Place Their Bets

In other news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.